Natural Biogenex and Fermbox Bio Enter Strategic Framework and Manufacturing Agreements to Strengthen Fermentation-Based CDMO Capabilities

Natural Biogenex Private Limited, a subsidiary of Natural Capsules Limited, has executed definitive Framework and Contract Manufacturing Agreements with Fermbox Bio Private Limited to jointly advance fermentation-based Contract Development and Manufacturing (CDMO) services. Under this collaboration, Fermbox will provide advanced fermentation technology and equipment placement of up to ₹60 crore at NBPL's state-of-the-art facility in Tumkur, while NBPL will undertake licensed manufacturing, quality assurance and regulatory compliance. The partnership positions the Company to serve global biotechnology and biopharma clients with integrated, GMP-compliant manufacturing capacity and enhanced process efficiency.

The global biotech and biopharma CDMO market continues to present strong growth opportunities, driven by rising demand, increasing outsourcing, and more complex biomanufacturing requirements. India is strategically placed to capture a meaningful share of this opportunity, tapping into its biomanufacturing strength and a growing CDMO sector.

Key government catalysts like the BioE3 Policy and the RDI initiative are helping accelerate innovation and scale-up, while strengthening India's broader biomanufacturing ecosystem. This collaboration is aligned to benefit from that momentum.
Comment from Managing Director, Mr. Sunil Laxminarayana Mundra: "This partnership marks a pivotal step for Natural Biogenex and, by extension, for Natural Capsules Group, in expanding into high-value, fermentation-based bio-manufacturing CDMO service for pharma and allied products. The collaboration with Fermbox combines our licensed manufacturing strength and regulatory excellence with their advanced technology, enabling valueaccretive, scalable growth in both pharmaceutical and industrial biotech segments."

Shares of NATURAL CAPSULES LTD. was last trading in BSE at Rs. 148.00 as compared to the previous close of Rs. 150.90. The total number of shares traded during the day was 336 in over 4 trades.

The stock hit an intraday high of Rs. 151.65 and intraday low of 148.00. The net turnover during the day was Rs. 50469.00.

Source : Equity Bulls

Keywords

NATURALCAPSULES INE936B01015 Pharmaceuticals NaturalBiogenex